About Bioterm Pharmaceuticals
Bioterm Pharmaceuticals is a Healthcare company based in Tel Aviv (Israel) founded in 2002. Bioterm Pharmaceuticals develops drugs for treating and preventing pre-term labor and inducing labor. It operates on a B2B model. The company has 204 employees. Its Indian entity Erm India Private Limited reported revenue of ₹147 Cr. Its focus areas include Pharmaceuticals, Drug Development and Labor Treatment.
Company details
Bioterm Pharmaceuticals bioterm pharmaceuticals develops drugs for treating and preventing pre-term labor and inducing labor, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and labor treatment. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Tel Aviv, Israel
- Employees 204
- SectorsHealthcare
- Website bio-term.com
- Legal Name Erm India Private Limited
- Date of Incorporation 19 May, 1995
- Jurisdiction Delhi, India
- Indian entity revenue₹147 Cr
FY 2025 · +12% YoY
- Indian entity net profit₹12.10 Cr
FY 2025 · 8% margin
- Indian entity EBITDA₹18.12 Cr
FY 2025 · 12% margin
- Employee Count204
Associated legal entities of Bioterm Pharmaceuticals
Bioterm Pharmaceuticals operates through Erm India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Erm India Private Limited CIN U74899DL1995PTC068804 | Active | 19 May 1995 | Delhi, Delhi | ₹147 Cr | 204 | 3 | View details |
Board of directors of Erm India Private Limited (Bioterm Pharmaceuticals)
Erm India Private Limited is the primary company behind Bioterm Pharmaceuticals. The board of Erm India Private Limited currently have 3 directors; the longest-serving is Nicole Maree Tannock, appointed in 2022. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nicole Maree Tannock DIN 09462784 | Director | 11 Jan 2022 | 4 yrs 9 mo | Erm India Private Limited |
| Jaydeep Sathaye DIN 06917417 | Director | 27 May 2022 | 4 yrs 4 mo | Erm India Private Limited |
| Rahul Mehta DIN 07237563 | Director | 28 Jul 2023 | 3 yrs 2 mo | Erm India Private Limited |
Financials of Bioterm Pharmaceuticals
Figures of Erm India Private Limited, the primary company behind Bioterm Pharmaceuticals, for FY 2025. Revenue was ₹147 Cr (+12% year on year). Net profit was ₹12.10 Cr (8% margin). EBITDA was ₹18.12 Cr (12% margin). Revenue has grown at a compounded annual rate of +8% over three years and +9% over five years.
- ₹147 CrRevenue · FY 2025 · +12% YoY
- ₹12.10 CrNet profit · 8% margin
- ₹18.12 CrEBITDA · 12% margin
- ₹30 LakhPaid-up capital
- 204Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Erm India Private Limited are on its company page.
Detailed financial statements for Bioterm Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioterm Pharmaceuticals
Complete news archive for Bioterm Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioterm Pharmaceuticals
Bioterm Pharmaceuticals was founded in 2002.
Bioterm Pharmaceuticals is headquartered in Tel Aviv, Israel.
Bioterm Pharmaceuticals has 204 employees.
The primary company behind Bioterm Pharmaceuticals, Erm India Private Limited, reported revenue of ₹147 Cr for FY 2025, up 12% year on year.
Bioterm Pharmaceuticals bioterm pharmaceuticals develops drugs for treating and preventing pre-term labor and inducing labor, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and labor treatment. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Bioterm Pharmaceuticals operates through Erm India Private Limited.
The legal entities of Bioterm Pharmaceuticals currently have 3 directors, including Rahul Mehta, Nicole Maree Tannock, Jaydeep Sathaye.